CoChat
Sign Up
Cited by 69Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Monitoring Glycemic Control

Open access
Berard, Lori D., Siemens, Rick, Woo, Vincent·2018·Canadian Journal of Diabetes
DOI 10.1016/j.jcjd.2017.10.007
Open this paper in CoChat — free accountOpen PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcjd.2017.10.007

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Continuous access to CGM for daily use is suggested for people living with T2DM at higher risk of hypoglycaemia, similar to current CGM clinical practice guideline recommendations from Diabetes Canada and the American Association of Clinical Endocrinologists.

    “Continuous access to CGM for daily use is suggested for people living with T2DM at higher risk of hypoglycaemia, similar to the current CGM clinical practice guideline recommendations from Diabetes Canada 56 and the American Association of Clinical Endocrinologists. 57”

    From Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials (2025) · cites this paper as [56]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological varia- tion have greater influence on HbA1c levels than glucose instability: An analy- sis of data from the Diabetes Control and Complications Trial. Diabetes Care 2006;29:352-5.
  2. Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. Diabe- tes Care 2004;27:1761-73.
  3. Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-72.
  4. American Diabetes Association, European Association for the Study of Diabe- tes, International Federation of Clinical Chemistry and Laboratory Medicine, Inter- national Diabetes Federation. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007;50:2042-3.
  5. Driskell OJ, Holland D, Waldron JL, et al. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control. Diabe- tes Care 2014;37:2731-7.
  6. Consensus Committee. Consensus statement on the worldwide standardiza- tion of the hemoglobin A1C measurement: The American Diabetes Associa- tion, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-400.
  7. Sacks DB. Measurement of hemoglobin A(1c): A new twist on the path to harmony. Diabetes Care 2012;35:2674-80.
  8. Weykamp C, John WG, Mosca A, et al. The IFCC Reference Measurement System for HbA1c: A 6-year progress report. Clin Chem 2008;54:240-8.
  9. Spaeth BA, Shephard MD, Schatz S. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care. Rural Remote Health 2014;14:2849.
  10. Saaddine JB, Fagot-Campagna A, Rolka D, et al. Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 2002;25:1326-30.
  11. Herman WH, Dungan KM, Wolffenbuttel BH, et al. Racial and ethnic differ- ences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009;94:1689- 94.
  12. Selvin E, Steffes MW, Ballantyne CM, et al. Racial differences in glycemic markers: A cross-sectional analysis of community-based data. Ann Intern Med 2011;154:303-9.
  13. Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: Implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012;97:1067-72.
  14. Bergenstal RM, Gal RL, Connor CG, et al. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med 2017;167:95-102.
  15. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardio- vascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
  16. Tsugawa Y, Mukamal KJ, Davis RB, et al. Should the hemoglobin A1c diagnos- tic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med 2012;157:153-9.
  17. Selvin E, Ning Y, Steffes MW, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2011;60:298-305.
  18. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes reg- istry. Am J Med 2001;111:1-9.
  19. Malekiani CL, Ganesan A, Decker CF. Effect of hemoglobinopathies on hemo- globin A1c measurements. Am J Med 2008;121:e5.
  20. Franciosi M, Pellegrini F, De Berardis G, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: An urgent need for better educational strategies. Diabetes Care 2001;24:1870-7.
  21. Polonsky WH, Earles J, Smith S, et al. Integrating medical management with diabetes self-management training: A randomized control trial of the Diabe- tes Outpatient Intensive Treatment program. Diabetes Care 2003;26:3048- 53.
  22. Sheppard P, Bending JJ, Huber JW. Pre-and post-prandial capillary glucose self- monitoring achieves better glycaemic control than pre-prandial only monitor- ing. Pract Diab Int 2005;22:15-22.
  23. Murata GH, Shah JH, Hoffman RM, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003;26:1759-63.
  24. The Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes melli- tus. N Engl J Med 1993;329:977-86.
  25. Gale EA, Tattersall RB. Unrecognised nocturnal hypoglycaemia in insulin- treated diabetics. Lancet 1979;1:1049-52.
  26. Vervoort G, Goldschmidt HM, van Doorn LG. Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or = 4) daily insulin injec- tion regimens. Diabet Med 1996;13:794-9.
  27. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998;338:1657-62.
  28. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care 1997;20:1482-6.
  29. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001;24:979-82.
  30. Coster S, Gulliford MC, Seed PT, et al. Self-monitoring in Type 2 diabetes mellitus: A meta-analysis. Diabet Med 2000;17:755-61.
  31. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: A systematic review. Diabetes Care 2005;28:1510-17.
  32. Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 2006;29:1764-70.
  33. Davis WA, Bruce DG, Davis TME. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510-15.
  34. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open par- allel group randomised trial. BMJ 2007;335:132.
  35. Allemann S, Houriet C, Diem P, et al. Self-monitoring of blood glucose in non- insulin treated patients with type 2 diabetes: A systematic review and meta- analysis. Curr Med Res Opin 2009;25:2903-13.
  36. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: A Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006;22:671-81.
  37. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: What is the evidence? Diabetes Metab Res Rev 2007;23:423-40.
  38. St John A, Davis WA, Price CP, et al. The value of self-monitoring of blood glucose: A review of recent evidence. J Diabetes Complications 2010;24:129- 41.
  39. Towfigh A, Romanova M, Weinreb JE, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: A meta-analysis. Am J Manag Care 2008;14:468-75.
  40. Canadian Agency for Drugs and Technologies in Health (CADTH). Systematic review of use of blood glucose test strips for the management of diabetes mel- litus. CADTH Technol Overv 2010;1:e0101.
  41. Skeie S, Kristensen GB, Carlsen S, et al. Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: Focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. J Diabetes Sci Technol 2009;3:83-8.
  42. Duran A, Martin P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010;2:203-11.
  43. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
  44. Notice: New requirements for medical device licence applications for lancing devices and blood glucose monitoring systems [press release]. Ottawa, 2014.
  45. Bergenstal R, Pearson J, Cembrowski GS, et al. Identifying variables associated with inaccurate self-monitoring of blood glucose: Proposed guidelines to improve accuracy. Diabetes Educ 2000;26:981-9.
  46. Bina DM, Anderson RL, Johnson ML, et al. Clinical impact of prandial state, exer- cise, and site preparation on the equivalence of alternative-site blood glucose testing. Diabetes Care 2003;26:981-5.
  47. Jungheim K, Koschinsky T. Glucose monitoring at the thenar: Evaluation of upper dermal blood glucose kinetics during rapid systemic blood glucose changes. Horm Metab Res 2002;34:325-9.
  48. Bektas F, Eray O, Sari R, et al. Point of care blood ketone testing of diabetic patients in the emergency department. Endocr Res 2004;30:395-402.
  49. Khan AS, Talbot JA, Tieszen KL, et al. Evaluation of a bedside blood ketone sensor: The effects of acidosis, hyperglycaemia and acetoacetate on sensor perfor- mance. Diabet Med 2004;21:782-5.
  50. Guerci B, Benichou M, Floriot M, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during meta- bolic deterioration after continuous subcutaneous insulin infusion interrup- tion in type 1 diabetic patients. Diabetes Care 2003;26:1137-41.
  51. Guerci B, Floriot M, Bohme P, et al. Clinical performance of CGMS in type 1 dia- betic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 2003;26:582-9.
  52. Deiss D, Bolinder J, Riveline J-P, et al. Improved glycemic control in poorly con- trolled patients with type 1 diabetes using real-time continuous glucose moni- toring. Diabetes Care 2006;29:2730-2.
  53. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Bode B, Beck RW, et al. Sustained benefit of continuous glucose moni- toring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabe- tes. Diabetes Care 2009;32:2047-9.
  54. O'Connell MA, Donath S, O'Neal DN, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: A randomised controlled trial. Diabetologia 2009;52:1250-7.
  55. Raccah D, Sulmont V, Reznik Y, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: The RealTrend study. Diabetes Care 2009;32:2245-50.
  56. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation con- tinuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
  57. Battelino T, Phillip M, Bratina N, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795-800.
  58. Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs con- ventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: The GOLD randomized clinical trial. JAMA 2017;317:379-87.
  59. Chase HP, Beck RW, Xing D, et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foun- dation continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010;12:507-15.
  60. Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, et al. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab 2009;35:312-18.
  61. Haak T, Hanaire H, Ajjan R, et al. Flash glucose-sensing technology as a replace- ment for blood glucose monitoring for the management of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial. Diabe- tes Ther 2017;8:55-73.
  62. Rohlfing CL, Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8.
  63. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.

Cited by

Sorted by citations

Authors
Berard, L. D., Siemens, R., & Woo, V.
ORCID
Venue
Canadian Journal of Diabetes
Publisher
Elsevier BV
Published
2018-04
Volume
42
Pages
S47-S53
ISSN
1499-2671 (ISSN-L)
DOI
10.1016/j.jcjd.2017.10.007
OpenAlex
W4252245568
Cited by
69
References
23
Citations by year
2026: 7 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 7 · 2018: 2
FWCI
5.97
Type
journal article
Language
en
Open access
Licence
Locations
Canadian Journal of Diabetes (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glycemic control monitoring, HbA1c, blood glucose, red blood cell turnover, hemoglobin variants, diabetes mellitus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review